Basecamp Research is a London biotech founded in 2019 by Dr Glen Gowers and Dr Oliver Vince. It trains EDEN, a family of biological foundation AI models, on proprietary genomic data collected through access and benefit-sharing partnerships in more than 30 countries across all seven continents, and uses them to design therapeutics – with a lead focus on in-vivo cell therapies for cancer and autoimmune disease.
London biotech training EDEN biological foundation models on a 30-country biodiversity data network to design new therapeutics, including in-vivo cell therapies.
This profile is maintained by the Sesamers data desk. Claim it to edit details, post jobs and answer interviews.
$225M
Total raised
-
Valuation
-
Employees
2019
Founded
Latest round
Series C - September 23, 2026
Series C - €120,000,000
September 23, 2026 · Read the story
Anthropic's Anthology Fund, Catalio Capital Management, European Tech Collective, Firebrand River Capital, Inception Fund, King Philanthropies, NATO Innovation Fund, Nvidia, PostScriptum, Redalpine, The Rockefeller Foundation, Singular, Sovereign AI, True Ventures
✓ verified by our desk
In the news
View all →Open roles
Basecamp Research is not hiring through Sesamers right now.
Work here? Claim the profile and post roles.
Claim your profile